Centene (CNC) Issues FY18 Earnings Guidance

Centene (NYSE:CNC) issued an update on its FY18 earnings guidance on Monday morning. The company provided EPS guidance of $5.47-5.87 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.90. The company issued revenue guidance of $60-60.8 billion, compared to the consensus revenue estimate of $59.71 billion.

Shares of Centene (NYSE:CNC) opened at $105.97 on Wednesday. Centene has a one year low of $61.03 and a one year high of $106.74. The company has a current ratio of 0.99, a quick ratio of 0.99 and a debt-to-equity ratio of 0.71. The firm has a market cap of $18,290.00, a PE ratio of 21.89, a P/E/G ratio of 1.32 and a beta of 0.70.

Centene (NYSE:CNC) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $1.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.11. Centene had a net margin of 1.81% and a return on equity of 14.79%. The business had revenue of $11.90 billion for the quarter, compared to analysts’ expectations of $11.75 billion. During the same period in the previous year, the business earned $1.12 earnings per share. The company’s revenue was up 9.7% on a year-over-year basis. research analysts predict that Centene will post 4.99 EPS for the current year.

CNC has been the topic of a number of recent analyst reports. Jefferies Group lifted their price objective on shares of Centene from $98.00 to $112.00 and gave the company a buy rating in a research note on Friday, October 13th. Oppenheimer restated a buy rating and set a $105.00 price objective on shares of Centene in a research note on Friday, September 29th. Cantor Fitzgerald restated a buy rating and set a $107.00 price objective on shares of Centene in a research note on Tuesday, October 24th. Cowen restated a buy rating and set a $115.00 price objective on shares of Centene in a research note on Tuesday, October 24th. Finally, Zacks Investment Research upgraded shares of Centene from a hold rating to a buy rating and set a $107.00 price objective on the stock in a research note on Friday, September 15th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of Buy and an average price target of $104.21.

In related news, EVP Jesse N. Hunter sold 10,000 shares of Centene stock in a transaction dated Tuesday, December 19th. The stock was sold at an average price of $98.73, for a total value of $987,300.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Robert K. Ditmore sold 4,167 shares of Centene stock in a transaction dated Thursday, October 26th. The stock was sold at an average price of $90.42, for a total value of $376,780.14. The disclosure for this sale can be found here. Over the last quarter, insiders sold 27,917 shares of company stock worth $2,777,255. 3.00% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: This news story was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://www.com-unik.info/2018/01/10/centene-cnc-issues-fy18-earnings-guidance-2.html.

About Centene

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.

Earnings History and Estimates for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit